RUO supply, COSHH and the purchaser’s own lab responsibilities when updating a laboratory SOP

# Rewriting a Laboratory SOP? Put RUO Supply, COSHH and Purchaser Duty on the Same Page

A laboratory SOP rarely fails because the science is wrong. It fails because the boundary between what the supplier guarantees and what the purchaser must assess was never written down. When a protocol is updated to bring in new research materials, the document has to state who supplies what, who assesses what, and who stays accountable once a vial crosses the threshold. For research-use-only (RUO) materials, that boundary matters more than it does for ordinary consumables, because the label carries legal and practical weight.

Research Sciences supplies high-purity research peptides, laboratory accessories and preparation tools strictly for controlled in-vitro scientific research. Its stated position is that products carry the label “For Research Use Only – Not for Human Consumption”, described by the shop as being in line with MHRA guidance — presented as the company’s compliance stance rather than as legal advice. The same position is clear that products are not medicines, medical devices, injectables, treatments or food supplements under UK law, and are not supplied for therapeutic, clinical or diagnostic purposes.

That label moves responsibility downstream. The purchaser is responsible for lawful use, safe handling, storage and disposal, for compliance with relevant UK regulations including COSHH and laboratory safety standards, and for checking that a material is suitable for the intended research application. COSHH is an employer-led assessment regime: it asks what the substance is, how it will be used, who could be exposed, and what controls keep exposure as low as is reasonably practicable. None of that can be outsourced to a supplier, and none of it is answered by a purity figure.

It is also worth separating two documents that are often filed together and should not be. A certificate of analysis is an analytical record of purity and identity for a batch; a COSHH assessment is a risk-management record for your workplace. Filing a CoA in place of an assessment leaves a gap that an auditor, an inspector or a new starter will eventually find.

The shop states that it does not provide therapeutic, medical, performance, injection, ingestion or dosing guidance, and that orders inconsistent with its compliance standards may be refused. For SOP authors this is a useful design constraint: the procedure should never depend on supplier instructions for a safety-critical step. It should name the internal assessment reference, the trained operator, the designated storage location and the waste route instead.

## Documentation, Storage and Handling: What the Updated SOP Should Capture

### Build the paper trail first

Every compound is described as including a CoA (HPLC) for purity and identity; manufacture is by international partners using solid-phase peptide synthesis, with independent HPLC testing and final verification and quality checks in the UK before release. The homepage lists “CoAs Janoshik Analytical Reports”, and the sensible habit is to open and read the CoA that accompanies the specific batch rather than one carried over from an earlier run. Vial labels combine a SKU code and an expiry date, for example BPC10-03/27, giving a reference to quote when querying documentation. Restocked products may carry the same Internal Test Reference as earlier stock; that reference links to associated sample testing reports, but it does not confirm that separate deliveries came from the same production lot or were independently tested. Cap colour varies and is not an indicator of identity, analytical quality or manufacturing origin.

### Write the storage parameters into the procedure

Lyophilised peptides are stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light. Allow vials to reach room temperature before opening, work in a clean environment, remove only the amount required for the experiment, and avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use. Reconstitution language belongs firmly inside the in-vitro workflow: diluent volume and target concentration for the assay in hand. The free reconstitution calculator on the site (mg, mcg, mL, U-100 and U-50 syringe scales, with optional IU conversion where a conversion factor is known) exists for laboratory research only and must never be used for human or veterinary dosing.

### Account for excipients and catalogue choices

The FAQs state that all peptides contain trace amounts of mannitol, used to support lyophilisation, solubility and stability in storage; note it in the COSHH assessment rather than discovering it during a review. The shop does not supply blended peptides, recommending instead that researchers buy individual materials and combine them only within a controlled experimental design, which is simpler to risk-assess and simpler to document. Materials managers assembling an approved-supplier schedule can cross-check the current research-use-only catalogue — Peptides uk — against the SOP’s permitted list before sign-off, and record the version reviewed.

## Fulfilment, Waste and Keeping the SOP Current

Waste handling deserves its own subsection rather than a line in an appendix. Decide in advance how unused material, spent diluent and contaminated consumables will be segregated, contained and disposed of under local rules, and record who is competent to do it. Training records, spill response and decontamination steps should sit alongside the storage instruction, not in a separate document nobody opens. Every material remains research-use-only and is not for human or veterinary use; the SOP should say so plainly so the wording survives staff turnover.

The published fulfilment terms are worth reflecting in procurement sections. Orders are dispatched the next working day, shipped by Royal Mail Tracked 24, which usually delivers the following working day according to Royal Mail’s estimate, with a tracking number issued after dispatch. The homepage’s “24hr UK Delivery” line is marketing wording: treat delivery times as estimates that can shift in peak periods, and do not build an assay date around a guaranteed arrival. No returns are accepted once dispatched, given the specialist and perishable nature of the goods; refunds apply only to damage, incorrect supply or quality issues, as set out in the Refunds & Returns Policy. Temperature-aware storage and tracked domestic fulfilment are described on the site.

Headline claims also need periodic reconciliation. The site publishes “≥99% Verified Purity”, “3,000+ UK Orders” and “7 Days Expert Customer Support”, and states that peptides are typically supplied at ≥99% purity by HPLC, with exact purity stated on the CoA. Treat those as published wording at the time of writing, reconfirm them on the live page, and rely on the batch CoA for the figure that matters to your assay.

Finally, give the SOP review triggers rather than a calendar date alone: a new material, a new lot, a change of room or equipment, a new operator, or a change in supplier wording. Keep a version history and re-issue the document when the supplier’s stated position or documentation changes. The shop’s compliance language, including its research-use-only framing, should be quoted accurately and dated in your file notes.